AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Blowfish Nasogastric Tube TM (BNGT)

Technology Benefits
ΓÇó Compatible with other intraluminal tubesΓÇó Addresses multiple functions in addition to nasogastric decompressionΓÇó Provides adequate suction without requiring monitoringΓÇó Increases productivity
Technology Application
ΓÇó Alleviates a distended stomach ΓÇó Prevents abdominal distension prophylactically, for instance in a surgical patientΓÇó All intubated patients (on a ventilator) in an ICU require nasogastric decompressionΓÇó Minimize stomach secretions
Detailed Technology Description
None
*Abstract
Dr. Steven Leeds has invented the BlowfishTM nasogastric tube (BNGT), a novel device that addresses a common problem that affects many patients that are admitted to hospital. The unique design ensures constant negative pressure while providing adequate suction of the stomach contents, thereby greatly reducing the need for frequent monitoring and repositioning the tube by medical personnel. In addition to optimizing the delivery of safe and effective patient care, the BNGT increases productivity and frees up medical staff to attend to other patient needs, while optimizing the purpose of the tubeΓÇÖs placement ensuring its function.MarketIt is well known that access to the stomach provides an advantage for care givers with patients that have gastrointestinal distress. This access provides the ability to aspirate contents of the stomach for decompression and provide nutrition or medications. For a surgeon, the most common use of a nasogastric tube is for small bowel obstruction. This occurs in about 3% of all open abdominal operations. In North America, there are about 300,000 hospital admissions annually for small bowel obstructions, accounting for 850,000 days of inpatient hospital care. These admissions cost about $1.3 billion annually and small bowel obstructions account for about 2,000 deaths annually. One of the functions that is widely used when using a nasogastric tube is aspiration of stomach contents, also referred to as nasogastric decompression. However, maintaining the proper function of the tube is often challenging and time-consuming, which requires constant monitoring and repositioning the tube by medical personnel. Therefore, there is great need to develop novel nasogastric (NG) tube that can provide adequate suction without requiring monitoring. TechnologyOur BNGT technology includes a plurality of deployable tines each coupled to the tube, where each tine is movable from a collapsed state to a deployed state. Unlike currently available devices, the unique BNGT design ensures constant negative pressure while providing adequate suction of the stomach contents, thereby greatly reducing the need for frequent monitoring and repositioning the tube by medical personnel.
*Principal Investigator

Name: Steven Leeds

Department:

Country/Region
USA

For more information, please click Here
Mobile Device